Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
March 28, 2024
Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of ...
Blog Post
March 14, 2024
Since its inception, DFC has demonstrated its capacity to rapidly increase its investment volume, making use of a higher portfolio cap. Its annual commitments have doubled over the past four years. But the agency has been subject to criticism (including from some at CGD) for insufficiently prioritiz...
Blog Post
February 26, 2024
As policymakers and financiers set their priorities for 2024, we gathered a group of experts who've been working on pandemics and pandemic financing from a range of perspectives including epidemiology, economics, insurance, policy, and advocacy. The purpose of our event was to map out the next steps...
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 28, 2023
We’d been eagerly awaiting an update to DFC’s downloadable project data for insight into the development finance agency’s recent investments and overarching portfolio composition. A new drop finally came earlier this month detailing transactions through FY2022 and timed with the release of DFC’s ina...
Blog Post
July 27, 2023
Last week’s Senate Appropriations Committee markup revealed a vast gulf dividing the Capitol with respect to development and diplomacy funding for the coming fiscal year. The two chambers’ State and Foreign Operations spending bill toplines are more than $9 billion apart, with the House coming in at...